{"transactions":[{"id":2696484,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":139051,"kind":"organization","name":"Big Rock Partners Sponsor, LLC","position":1,"cik":"0001723217","reported_name":"Big Rock Partners Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":139052,"kind":"person","name":"ACKERMAN RICHARD","position":2,"cik":"0001724016","reported_name":"ACKERMAN RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Unit Purchase Option","published_at":"2021-05-26T01:17:34.000Z","date":"2021-05-24","kind":"purchase","acquired":true,"shares":100000,"price":1,"value":100000.0,"ownership":{"direct":false,"nature":"By A/Z Property Partners LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Ackerman is the majority owner of this entity and may be deemed to have beneficial ownership of the shares owned thereby. Mr. Ackerman disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":100000,"derivative":{"exercise_price":10,"exercise_date":"2021-05-24","expiration_date":"2022-11-20","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001094891-21-000212","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719406/000109489121000212/edgar.xml","form_type":"4"}},{"id":2696483,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":139051,"kind":"organization","name":"Big Rock Partners Sponsor, LLC","position":1,"cik":"0001723217","reported_name":"Big Rock Partners Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":139052,"kind":"person","name":"ACKERMAN RICHARD","position":2,"cik":"0001724016","reported_name":"ACKERMAN RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Rights, exchangeable for Common Stock","published_at":"2021-05-26T01:17:34.000Z","date":"2021-05-24","kind":"exercise","acquired":false,"shares":272500,"ownership":{"direct":false,"nature":"By Big Rock Partners Sponsor, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each of the Issuer's Rights were convertible into 1/10 of one share of the Issuer's common stock upon consummation of the Issuer's initial business combination and had no expiration\ndate. In connection with the Issuer's business combination, such Rights automatically converted into shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each of the Issuer's Rights were convertible into 1/10 of one share of the Issuer's common stock upon consummation of the Issuer's initial business combination and had no expiration\ndate. In connection with the Issuer's business combination, such Rights automatically converted into shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each of the Issuer's Rights were convertible into 1/10 of one share of the Issuer's common stock upon consummation of the Issuer's initial business combination and had no expiration\ndate. In connection with the Issuer's business combination, such Rights automatically converted into shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each of the Issuer's Rights were convertible into 1/10 of one share of the Issuer's common stock upon consummation of the Issuer's initial business combination and had no expiration\ndate. In connection with the Issuer's business combination, such Rights automatically converted into shares of common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Ackerman is the managing member of this entity and has the sole voting and dispositive power of the securities held thereby. Accordingly, Mr. Ackerman may be deemed to have beneficial ownership of such shares. Mr. Ackerman disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27250},"source":{"system":"sec-edgar","filing":"0001094891-21-000212","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719406/000109489121000212/edgar.xml","form_type":"4"}},{"id":2696482,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":139051,"kind":"organization","name":"Big Rock Partners Sponsor, LLC","position":1,"cik":"0001723217","reported_name":"Big Rock Partners Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":139052,"kind":"person","name":"ACKERMAN RICHARD","position":2,"cik":"0001724016","reported_name":"ACKERMAN RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-26T01:17:34.000Z","date":"2021-05-24","kind":"exercise","acquired":true,"shares":27250,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Big Rock Partners Sponsor, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Ackerman is the managing member of this entity and has the sole voting and dispositive power of the securities held thereby. Accordingly, Mr. Ackerman may be deemed to have beneficial ownership of such shares. Mr. Ackerman disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":519315,"source":{"system":"sec-edgar","filing":"0001094891-21-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1719406/000109489121000212/edgar.xml","form_type":"4"}},{"id":2696481,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":139051,"kind":"organization","name":"Big Rock Partners Sponsor, LLC","position":1,"cik":"0001723217","reported_name":"Big Rock Partners Sponsor, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":139052,"kind":"person","name":"ACKERMAN RICHARD","position":2,"cik":"0001724016","reported_name":"ACKERMAN RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-05-26T01:17:34.000Z","date":"2021-05-24","kind":"disposition_to_issuer","acquired":false,"shares":5435,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Big Rock Partners Sponsor, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Ackerman is the managing member of this entity and has the sole voting and dispositive power of the securities held thereby. Accordingly, Mr. Ackerman may be deemed to have beneficial ownership of such shares. Mr. Ackerman disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":492065,"source":{"system":"sec-edgar","filing":"0001094891-21-000212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719406/000109489121000212/edgar.xml","form_type":"4"}},{"id":3755960,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":139052,"kind":"person","name":"ACKERMAN RICHARD","position":1,"cik":"0001724016","reported_name":"ACKERMAN RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"President and CEO"}},{"id":139051,"kind":"organization","name":"Big Rock Partners Sponsor, LLC","position":2,"cik":"0001723217","reported_name":"Big Rock Partners Sponsor, LLC","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-11-21T00:49:20.000Z","date":"2018-11-20","kind":"sale","acquired":false,"shares":1500000,"ownership":{"direct":false,"nature":"Big Rock Partners Sponsor, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement among Big Rock Partners Acquisition Corp. (the \"Issuer\"), Big Rock Partners Sponsor, LLC (the \"Sponsor\") and BRAC Lending Group LLC (the \"Investor\"), the Sponsor transferred 1,500,000 shares of common stock of the Issuer in exchange for the terms set forth in the Agreement and an aggregate cash consideration of $1.00. For a description and copy of the Agreement, see the Issuer's Form 8-K filed with the SEC on 11/20/2018."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Ackerman is the Issuer's President, Chairman and Chief Executive Officer and the managing member of the Sponsor and has the sole voting and dispositive power of the securities held by the Sponsor. Accordingly, Mr. Ackerman may be deemed to have beneficial ownership of such shares."}],"balance_after":225000,"source":{"system":"sec-edgar","filing":"0001654954-18-013065","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719406/000165495418013065/section16.xml","form_type":"4"}},{"id":4143838,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":139052,"kind":"person","name":"ACKERMAN RICHARD","position":1,"cik":"0001724016","reported_name":"ACKERMAN RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}},{"id":139051,"kind":"organization","name":"Big Rock Partners Sponsor, LLC","position":2,"cik":"0001723217","reported_name":"Big Rock Partners Sponsor, LLC","relationship":{"ten_percent_owner":true}}],"security":"Warrant","published_at":"2017-12-05T01:23:27.000Z","date":"2017-11-29","kind":"purchase","acquired":true,"shares":11250,"ownership":{"direct":false,"nature":"Big Rock Partners Sponsor, LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying units of the issuer. Each unit consists of one share of common stock, one right to receive one-tenth of one share of common stock upon the consummation of the issuer's initial business combination and one-half of one warrant, each whole warrant entitling the holder to purchase one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents securities purchased upon the exercise of the underwriters' over-allotment option in connection with the issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each whole warrant will become exercisable on the later of the completion of the issuer's initial business combination and 12 months from the closing of the issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each warrant will expire on the fifth anniversary of the completion of the issuer's initial business combination, or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Ackerman is the issuer's President, Chairman and Chief Executive Officer and the managing member of Big Rock Partners Sponsor, LLC (the \"Sponsor\") and has the sole voting and dispositive power of the securities held by the Sponsor. Accordingly. Mr. Ackerman may be deemed to have beneficial ownership of such shares."}],"balance_after":136250,"derivative":{"exercise_price":11.5,"underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001654954-17-011320","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1719406/000165495417011320/section16.xml","form_type":"4"}},{"id":4143837,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":139052,"kind":"person","name":"ACKERMAN RICHARD","position":1,"cik":"0001724016","reported_name":"ACKERMAN RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}},{"id":139051,"kind":"organization","name":"Big Rock Partners Sponsor, LLC","position":2,"cik":"0001723217","reported_name":"Big Rock Partners Sponsor, LLC","relationship":{"ten_percent_owner":true}}],"security":"Right to receive common stock","published_at":"2017-12-05T01:23:27.000Z","date":"2017-11-29","kind":"purchase","acquired":true,"shares":22500,"ownership":{"direct":false,"nature":"Big Rock Partners Sponsor, LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying units of the issuer. Each unit consists of one share of common stock, one right to receive one-tenth of one share of common stock upon the consummation of the issuer's initial business combination and one-half of one warrant, each whole warrant entitling the holder to purchase one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each right entitles the holder to receive one-tenth (1/10) of one share of common stock upon consummation of the issuer's initial business combination."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents securities purchased upon the exercise of the underwriters' over-allotment option in connection with the issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each right entitles the holder to receive one-tenth (1/10) of one share of common stock upon consummation of the issuer's initial business combination."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"If the issuer fails to consummate an initial business combination within 12 months (or up to 18 months from the closing of the issuer's initial public offering, if the issuer extends the period of time to consummate a business combination as described in its amended and restated certificate of incorporation), the issuer will be dissolved and the rights will expire worthless."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Ackerman is the issuer's President, Chairman and Chief Executive Officer and the managing member of Big Rock Partners Sponsor, LLC (the \"Sponsor\") and has the sole voting and dispositive power of the securities held by the Sponsor. Accordingly. Mr. Ackerman may be deemed to have beneficial ownership of such shares."}],"balance_after":27250,"derivative":{"underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001654954-17-011320","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1719406/000165495417011320/section16.xml","form_type":"4"}},{"id":4143836,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":139052,"kind":"person","name":"ACKERMAN RICHARD","position":1,"cik":"0001724016","reported_name":"ACKERMAN RICHARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}},{"id":139051,"kind":"organization","name":"Big Rock Partners Sponsor, LLC","position":2,"cik":"0001723217","reported_name":"Big Rock Partners Sponsor, LLC","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2017-12-05T01:23:27.000Z","date":"2017-11-29","kind":"purchase","acquired":true,"shares":22500,"price":10,"value":225000.0,"ownership":{"direct":false,"nature":"Big Rock Partners Sponsor, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents securities underlying units of the issuer. Each unit consists of one share of common stock, one right to receive one-tenth of one share of common stock upon the consummation of the issuer's initial business combination and one-half of one warrant, each whole warrant entitling the holder to purchase one share of common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents securities purchased upon the exercise of the underwriters' over-allotment option in connection with the issuer's initial public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents securities underlying units of the issuer. Each unit consists of one share of common stock, one right to receive one-tenth of one share of common stock upon the consummation of the issuer's initial business combination and one-half of one warrant, each whole warrant entitling the holder to purchase one share of common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Ackerman is the issuer's President, Chairman and Chief Executive Officer and the managing member of Big Rock Partners Sponsor, LLC (the \"Sponsor\") and has the sole voting and dispositive power of the securities held by the Sponsor. Accordingly. Mr. Ackerman may be deemed to have beneficial ownership of such shares."}],"balance_after":272500,"source":{"system":"sec-edgar","filing":"0001654954-17-011320","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1719406/000165495417011320/section16.xml","form_type":"4"}}]}